Inclusion Criteria:  Histologically or cytologically confirmed advanced gastric cancer. Willing to receive anti-tumor drug treatment. Willing to provide residual tumor tissues after routine clinical diagnosis for tumor microenvironment detection analysis.  Exclusion Criteria:  Patients reject to participate in the study. Patients were ineligible for receiving anti-tumor drug therapy.